ROYAL BANK OF CANADA - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,079,000
-2.0%
46,646
+11.1%
0.00%
Q2 2023$1,101,000
+54.4%
41,987
+51.7%
0.00%
Q1 2023$713,000
-5.2%
27,677
-4.5%
0.00%
Q4 2022$752,000
-0.8%
28,967
+9.0%
0.00%
Q3 2022$758,000
+22.5%
26,581
+5.8%
0.00%
Q2 2022$619,000
-58.6%
25,134
-5.0%
0.00%
Q1 2022$1,494,000
-7.2%
26,465
+1.8%
0.00%
Q4 2021$1,610,000
+61.6%
25,986
+65.5%
0.00%
Q3 2021$996,000
+303.2%
15,702
+425.3%
0.00%
Q2 2021$247,000
+6.9%
2,989
-4.9%
0.00%
Q1 2021$231,000
+260.9%
3,142
+259.9%
0.00%
Q4 2020$64,000
+88.2%
873
+21.6%
0.00%
Q3 2020$34,000
+9.7%
718
-4.0%
0.00%
Q2 2020$31,000
+55.0%
748
+0.3%
0.00%
Q1 2020$20,0007460.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 3,081,307$79,3139.91%
Finepoint Capital LP 614,231$15,810,3066.04%
M28 Capital Management LP 197,700$5,088,7985.75%
Boxer Capital, LLC 3,421,541$88,0704.33%
Deep Track Capital, LP 3,100,000$79,794,0003.28%
EcoR1 Capital, LLC 3,460,208$89,065,7542.87%
Artal Group S.A. 1,817,349$46,7792.78%
Orbimed Advisors 4,498,900$115,801,6862.27%
Perceptive Advisors 2,079,352$53,522,5201.58%
SPHERA FUNDS MANAGEMENT LTD. 317,625$8,175,6681.37%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders